iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s stock price rose 0.4% during mid-day trading on Monday . The company traded as high as $35.43 and last traded at $35.32. 1,999 shares traded hands during trading, a decline of 15% from the average daily volume of 2,339 shares. The stock had previously closed at $35.19.
iShares Neuroscience and Healthcare ETF Trading Down 4.4%
The firm has a market cap of $6.82 million, a PE ratio of 15.61 and a beta of 0.76. The firm has a fifty day simple moving average of $38.22 and a two-hundred day simple moving average of $35.97.
iShares Neuroscience and Healthcare ETF Company Profile
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
